Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Long-Term Debt Repayments (2021 - 2024)

Historic Long-Term Debt Repayments for Serina Therapeutics (SER) over the last 3 years, with Q4 2024 value amounting to $1000.0.

  • Serina Therapeutics' Long-Term Debt Repayments fell 9230.77% to $1000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $1000.0, marking a year-over-year decrease of 9787.23%. This contributed to the annual value of $35000.0 for FY2024, which is 2708.33% down from last year.
  • Per Serina Therapeutics' latest filing, its Long-Term Debt Repayments stood at $1000.0 for Q4 2024, which was down 9230.77% from $8000.0 recorded in Q3 2024.
  • In the past 5 years, Serina Therapeutics' Long-Term Debt Repayments registered a high of $250000.0 during Q1 2021, and its lowest value of $1000.0 during Q4 2024.
  • Its 3-year average for Long-Term Debt Repayments is $37000.0, with a median of $12000.0 in 2023.
  • Examining YoY changes over the last 5 years, Serina Therapeutics' Long-Term Debt Repayments showed a top increase of 1818.18% in 2024 and a maximum decrease of 9230.77% in 2024.
  • Quarter analysis of 3 years shows Serina Therapeutics' Long-Term Debt Repayments stood at $250000.0 in 2021, then plummeted by 94.8% to $13000.0 in 2023, then crashed by 92.31% to $1000.0 in 2024.
  • Its Long-Term Debt Repayments was $1000.0 in Q4 2024, compared to $8000.0 in Q3 2024 and $13000.0 in Q2 2024.